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Introduction 
Though lithium-induced neurotoxicity 
usually occurs when serum lithium exceeds 
2.0 mEq/1, reports document its occurrence 
with serum lithium within the therapeutic 
range (Strayhorn and Nash 1977, Hansen 
and Amidsen, 1978, Speirs and Hirsch 
1978, West and Meltzer 1979). Neuroto-
xicity has even been described with serum 
lithium between 0.4 and 0.5 mEq/1 (Han-
sen and Amidsen 1978). Such may best be 
conceptualized as pathological neurotoxic-
ity, in the sense that the expected side effect 
is obtained at a far lower dose or level than 
is usual. Many hypotheses have been sug-
gested to explain this pathological neuroto-
xicity. These include: interactions with 
other drugs such as haloperidol and diuret-
ics (Strayhorn and Nash 1977), diphenylhy-
dantoin (Speirs and Hirsch 1978) and phe-
nothiazines (Spring 1979), tissue retention 
and seizure diathesis (Strayhorn and Nash 
1977), high pretoxic global ratings of psy-
chotic symptomatology and anxiety (West 
and Meltzer 1979), old age (Van der Velde 
1971), Schizophrenia (Shopsin and Ger-
shon 1973) and intercurrent medical illness 
(Shopsin and Gershon 1973, Strayhorn and 
Nash 1977). 
Persistence of neurological deficits af-
ter recovery is also known, but not fol-
lowing pathological neurotoxicity (Han-
sen and Amidsen 1978, Schou 1984). Ce-
rebellar deficits are most common, but 
pyramidal signs or cognitive deficits may 
also occur (Schou, 1984). 
We present the course and outcome of a 
case of lithium-induced pathological neu-
rotoxicity, discuss certain unusual features, 
and suggest a hypothesis to explain our ob-
servations. 
Cast Report 
R., a 20 year old female, moderately 
mentally-retarded as per the diagnosis-at a 
previous consultation, was brought with a 4 
month history of psychological dysfunction 
fulfilling the criteria for a diagnosis of ma-
nia on DSM III. Physical examination was 
normal. She was started on lithium carbon-
ate, 300 mg thrice daily. Eight days later, no 
abatement in mania was observed, but bilat-
eral, horizontal, fixation nystagmus ap-
peared. No other deficits were seen. Over 
the next 4 days, drowsiness, confusion and 
disorientation supervened; manic features 
were no longer seen. Besides nystagmus, 
the following cerebellar signs appeared bi-
laterally: dysdiadoc ho kinesis, impaired 
heel to toe and finger-nose coordination, 
and gait ataxia. Bilateral pyramidal signs, 
more marked on the right side, were also 
present: spasticity, exaggerated tendon ref-
lexes, ankle and patellar clonus and upgoing 
plantars. Fundoscopic examination was 
normal. 
Lithium was immediately stopped and 
R. was extensively investigated. Serum li-
thium was 0.5 mEq/1. Haemogram, urina-
lysis, liver function tests, CSF analysis, 
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ECG, chest and skull X-Rays and CT scan 
were all normal. EEG revealed slowing of 
background alpha to 7-8 Hz., seen diffusely 
and with bilateral symmetry. 
Within 6 days of discontinuing lithium, 
the confusion, cerebellar signs and pyrami-
dal signs remitted and the manic picture 
reappeared. Nystagmus, however, persist-
ed. R. was administered 10 mg of haloperi-
dol daily, and was discharged euthymic, 2 
months later. Barring persistent nystagmus, 
physical examination was normal at dis-
charge. 
Discussion 
This case presents several unusual fea-
tures : a) neurotoxicity developed despite a 
serum lithium level of just 0.5 mEq/1. Lite-
rature describes just two cases where such 
pathological neurotoxicity has occurred at 
lower serum lithium levels (Hansen and 
Amidsen 1978), b) cerebellar signs were 
present early in the acute phase - in fact, 
nystagmus was the first neurological sign to 
appear. This contrasts with the observation 
of Schou (1984) that the acute phase of li-
thium neurotoxocity is without cerebellar 
symptoms; c) a long-term neurological de-
ficit (nystagmus) resulted. This conforms 
with Schou's (1984) observation that per-
sistent lithium-induced neurological seque-
lae (defined as those present more than 2 
months after acute intoxication) are most 
commonly cerebellar in locus, but is unu-
sual in that it occurred at a serum lithium 
level of 0.5 mEq/1. Schou's extensive re-
view does not describe any case where li-
thium-induced neurotoxic sequelae ob-
tained at serum lithium levels below 1.2 
mEq/1. 
Cases such as ours where intoxication 
(in the form of confusion with bilateral ce-
rebellar and pyramidal signs, the latter sug-
gestive of lateralization) occurs at a low se-
rum lithium level, present the clinician 
with a diagnostic dilemma. Invariably the 
parient needs to be investigated extensively 
for possible intracranial pathology, and se-
condary mania has to be kept in mind. The 
diagnosis is established only after all inves-
tigations draw a blank and the clinical pic-
ture normalizes with discontinuation of li-
thium. It has been suggested that diffuse 
slowing of the EEG (as in our case) may be 
of great, perhaps diagnostic, significance at 
such times (Spring 1979). 
Among the hypotheses proposed to ex-
plain lithium-induced pathological neuro-
toxicity are the following: seizure diathesis 
(Strayhorm and Nash 1977), increased age 
(Van der Velde 1971) and schizophrenia 
(Shopsin and Gershon 1973). A common 
theme in these is an increased incidence of 
underlying demonstrable cerebral patholo-
gy. In this context, subclinical cerebral im-
pairment has been proposed to be a predi-
sposing factor for lithium-induced neuroto-
xicity. (Speirs and Hirsch 1978, Ghadirian 
and Lehmann 1980). Interestingly, a simi-
lar hypothesis has been proposed for the de-
velopment of lithium carbamazepine neu-
rotoxicity with the levels of both drugs be-
ing within the therapeutic range (Shukla et 
al 1984). Cerebral impairment was unde-
niably present in our case, since R. was mo-
derately mentally retarded. 
Individuals with brain damage may be 
more vulnerable to lithium-induced neuro-
toxocity (and possibly to the subsequent 
persistence of deficits) even at therapeutic 
serum lithium levels. Lithium should the-
refore be used with caution in such cases. 
The risk of pathological neurotoxicity may 
also warrant routine close supervision of li-
thium therapy, especially when treatment 
is being initiated. 
References 
GHADIRIAN, A.M. & LEHMANN, H.E 
(1980), Neurological side effects of lithium. 
Comprehensive Psychiatry, 21, 327-335. 
HANSEN, H.E & AMIDSEN, A. (1978), CHITTARANJAN ANDRADE ET AL.  281 
Lithium intoxication. Quarterly Journal of 
Medicine, 47, 123-144. 
SCHOU, M. (1984), Long-lasting neurological 
sequelae after lithium intoxication. Acta Psy-
chiatrica Scandinavica, 70, 594-602. 
SHOPSIN, B. & GERSHON, S. (1973), Pharma-
cology-toxicology of the lithium ion. In Li-
thium: Its Role in Psychiatric Research and 
Treatment New York, Plenum Press. 
SHUKLA, S., GOODWIN, CD., LONG, 
L. E B. & MITTER, M. G. (1984), Lithium-
carbamazepine neurotoxicity and risk fac-
tors. American Journal of Psychiatry, 141, 
1604-1606. 
SPEIRS, J. & HIRSCH, S.R. (1978), Severe li-
thium neurotoxicity with 'normal' serum 
concentrations. British Medical Journal, 1, 
815-816. 
SPRING, G. K. (1979) EEG observations in con-
firming neurotoxicity (letter). American Jour-
nal of Psychiatry, 136, 1099-1100. 
STRAYHORN.J.M. & NASH, J. L. (1977), Se-
vere neurotoxicity despite 'therapeutic' se-
rum lithium levels. Diseases of the Nervous 
System, 38, 107-111. 
VAN DERVELDE, CD. (1971), Toxicity of li-
thium carbonate in elderly patients. Ameri-
can Journal of Psychiatry, 127, 1075-1077. 
WEST, A. P. & MELTZER, H.Y. (1979), Para-
doxical lithium neurotoxicity: a report of 5 
cases and a hypothesis about risk for neuro-
toxicity. American Journal of Psychiatry, 136, 
963-966. 